塞栓用粒子市場：製品タイプ、用途、エンドユーザー、材料、サイズ別-2025-2030年の世界予測

塞栓用粒子市場は、2023年に16億米ドルと評価され、2024年には17億9,000万米ドルに達すると予測され、CAGR 11.21%で成長し、2030年には33億7,000万米ドルになると予測されています。

塞栓粒子とは、医療処置において血管を塞ぐために使用される微小な球体やその他の形状の材料を指し、それによって出血を制御または予防したり、腫瘍への血液供給を遮断したり、動静脈奇形に対処したりします。子宮筋腫、肝臓がん、消化管出血のような複雑な病態の治療において、低侵襲性かつ有効性があるため、医療分野での必要性は大きいです。最終用途の範囲には主に、高度なインターベンショナル・ラジオロジー技術に依存する病院や専門的な臨床現場が含まれます。塞栓用粒子の市場成長は、低侵襲手術に対する需要の増加、放射線処置の進歩、血管疾患やがんにかかりやすい高齢化によってもたらされます。技術の進歩によってオーダーメイドの治療アプローチがより効果的になるにつれて、腫瘍学や個別化医療への応用が拡大する可能性があります。ヘルスケア・インフラが改善しつつある新興市場にも、市場拡大の有利な機会があります。企業は、生体適合性とターゲティング能力を強化した新規塞栓材料を開発する研究に投資することで、こうした機会を捉えることができます。しかし、高コスト、規制上の課題、手技に伴うリスクなどの制約が市場成長の障害となっています。また、インターベンショナル・ラジオロジーがまだ発展途上の地域では、このような手技を実施するためのトレーニングやスキル要件も足かせとなる可能性があります。技術革新の主な分野には、安全性と治療成果を高めることができる生分解性粒子や薬剤溶出性粒子の開発が含まれます。人工知能を活用することで、手技中の画像処理と照準精度を向上させることも成長の道となります。この市場は技術主導型であると同時に競争も激しく、継続的な技術革新と厳格な規制基準の遵守が求められます。企業は、臨床試験やフィードバックのためのヘルスケア機関との提携に注力するとともに、開発サイクルの早い段階で規制当局と連携し、承認プロセスを合理化して新製品の市場投入までの時間を短縮する必要があります。

市場力学：急速に進化する塞栓用粒子市場の主要市場インサイトを公開

塞栓用粒子市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • イメージング・モダリティとの技術統合により、塞栓術の精度と有効性が向上
  • ヘルスケア専門家向けのトレーニングプログラムの充実により、塞栓術の熟練度が向上
  • 患者中心のアプローチとカスタマイズされた治療計画が、塞栓術の実践において脚光を浴びる
• 市場抑制要因
  • 塞栓術の手技と粒子のコストが高い
• 市場機会
  • 低侵襲治療への需要の高まりが塞栓用粒子市場の成長を牽引
  • 塞栓用粒子の優れた性能と新たな用途につながる技術の進歩と革新
  • 塞栓用粒子技術の研究開発を後押しする政府と民間部門の投資
• 市場の課題
  • 塞栓術に伴う合併症とリスク

ポーターの5つの力：塞栓用粒子市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：塞栓用粒子市場における外部からの影響の把握

外部マクロ環境要因は、塞栓用粒子市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析塞栓用粒子市場における競合情勢の把握

塞栓用粒子市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス塞栓用粒子市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、塞栓用粒子市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨塞栓用粒子市場における成功への道筋を描く

塞栓用粒子市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 画像診断装置との技術統合により塞栓術の精度と有効性が向上します
    • ヘルスケア従事者向けの強化されたトレーニングプログラムにより、塞栓術技術の使用能力が向上します。
    • 患者中心のアプローチとカスタマイズされた治療計画が塞栓術の現場で重要視される
  • 抑制要因
    • 塞栓術と粒子の高コスト
  • 機会
    • 低侵襲手術の需要増加が成長を牽引塞栓用粒子市場
    • 優れた性能と塞栓粒子の新たな用途につながる技術の進歩と革新
    • 政府と民間部門の投資が塞栓用粒子技術の研究開発を促進
  • 課題
    • 塞栓術に伴う合併症とリスク
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 塞栓用粒子市場：製品タイプ別

• 薬剤溶出ビーズ
• マイクロスフィア
• PVA粒子
• 放射線塞栓粒子
• トリスアクリルゼラチン粒子

第7章 塞栓用粒子市場：用途別

• 神経学
• 腫瘍学
• 末梢血管疾患
• 泌尿器科

第8章 塞栓用粒子市場：エンドユーザー別

• 外来手術センター
• 病院
• 調査・学術機関
• 専門クリニック

第9章 塞栓用粒子市場：素材別

• アクリルポリマー
• ゼラチン
• ポリビニルアルコール（PVA）

第10章 塞栓用粒子市場：サイズ別

• 100～300ミクロン
• 300～500ミクロン
• 500～700ミクロン
• 700～900ミクロン
• 900ミクロン以上
• 100ミクロン未満

第11章 南北アメリカの塞栓用粒子市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第12章 アジア太平洋地域の塞栓用粒子市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第13章 欧州・中東・アフリカの塞栓用粒子市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第14章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• 1. ABK Biomedical
• 2. Bellostent
• 3. Biocompatibles International plc
• 4. Boston Scientific Corporation
• 5. BTG plc
• 6. Cook Medical
• 7. EndoShape
• 8. Guerbet Group
• 9. Hanger Inc.
• 10. Imbiotechnologies
• 11. Johnson & Johnson
• 12. Kaneka Corporation
• 13. Medtronic plc
• 14. Merit Medical Systems
• 15. Penumbra Inc.
• 16. Sequent Medical
• 17. Sirtex Medical
• 18. Stryker Corporation
• 19. Terumo Corporation

LIST OF FIGURES

• FIGURE 1. EMBOLIZATION PARTICLE MARKET RESEARCH PROCESS
• FIGURE 2. EMBOLIZATION PARTICLE MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2023 VS 2030 (%)
• FIGURE 15. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. AMERICAS EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. AMERICAS EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. UNITED STATES EMBOLIZATION PARTICLE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 19. UNITED STATES EMBOLIZATION PARTICLE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. ASIA-PACIFIC EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. ASIA-PACIFIC EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 23. EUROPE, MIDDLE EAST & AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 24. EMBOLIZATION PARTICLE MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 25. EMBOLIZATION PARTICLE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. EMBOLIZATION PARTICLE MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. EMBOLIZATION PARTICLE MARKET DYNAMICS
• TABLE 7. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY DRUG-ELUTING BEADS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY MICROSPHERES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY PVA PARTICLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY RADIOEMBOLIZATION PARTICLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY TRIS-ACRYL GELATIN PARTICLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY PERIPHERAL VASCULAR DISEASE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY UROLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY ACRYLIC POLYMERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY GELATIN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY POLYVINYL ALCOHOL (PVA), BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY 100-300 MICRONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY 300-500 MICRONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY 500-700 MICRONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY 700-900 MICRONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY 900 MICRONS AND ABOVE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY LESS THAN 100 MICRONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 35. AMERICAS EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 36. AMERICAS EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 37. AMERICAS EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 38. AMERICAS EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
• TABLE 39. AMERICAS EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 40. ARGENTINA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 41. ARGENTINA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 42. ARGENTINA EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 43. ARGENTINA EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 44. ARGENTINA EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
• TABLE 45. BRAZIL EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 46. BRAZIL EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 47. BRAZIL EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 48. BRAZIL EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 49. BRAZIL EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
• TABLE 50. CANADA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 51. CANADA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 52. CANADA EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 53. CANADA EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 54. CANADA EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
• TABLE 55. MEXICO EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 56. MEXICO EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 57. MEXICO EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 58. MEXICO EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 59. MEXICO EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
• TABLE 60. UNITED STATES EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 61. UNITED STATES EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 62. UNITED STATES EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 63. UNITED STATES EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 64. UNITED STATES EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
• TABLE 65. UNITED STATES EMBOLIZATION PARTICLE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 66. ASIA-PACIFIC EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 67. ASIA-PACIFIC EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 68. ASIA-PACIFIC EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 69. ASIA-PACIFIC EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 70. ASIA-PACIFIC EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
• TABLE 71. ASIA-PACIFIC EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 72. AUSTRALIA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 73. AUSTRALIA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 74. AUSTRALIA EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 75. AUSTRALIA EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 76. AUSTRALIA EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
• TABLE 77. CHINA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 78. CHINA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 79. CHINA EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 80. CHINA EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 81. CHINA EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
• TABLE 82. INDIA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 83. INDIA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 84. INDIA EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 85. INDIA EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 86. INDIA EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
• TABLE 87. INDONESIA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 88. INDONESIA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 89. INDONESIA EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 90. INDONESIA EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 91. INDONESIA EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
• TABLE 92. JAPAN EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 93. JAPAN EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 94. JAPAN EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 95. JAPAN EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 96. JAPAN EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
• TABLE 97. MALAYSIA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 98. MALAYSIA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 99. MALAYSIA EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 100. MALAYSIA EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 101. MALAYSIA EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
• TABLE 102. PHILIPPINES EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 103. PHILIPPINES EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 104. PHILIPPINES EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 105. PHILIPPINES EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 106. PHILIPPINES EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
• TABLE 107. SINGAPORE EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 108. SINGAPORE EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 109. SINGAPORE EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 110. SINGAPORE EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 111. SINGAPORE EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
• TABLE 112. SOUTH KOREA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 113. SOUTH KOREA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 114. SOUTH KOREA EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 115. SOUTH KOREA EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 116. SOUTH KOREA EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
• TABLE 117. TAIWAN EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 118. TAIWAN EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 119. TAIWAN EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 120. TAIWAN EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 121. TAIWAN EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
• TABLE 122. THAILAND EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 123. THAILAND EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 124. THAILAND EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 125. THAILAND EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 126. THAILAND EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
• TABLE 127. VIETNAM EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 128. VIETNAM EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 129. VIETNAM EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 130. VIETNAM EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 131. VIETNAM EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
• TABLE 132. EUROPE, MIDDLE EAST & AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 133. EUROPE, MIDDLE EAST & AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 134. EUROPE, MIDDLE EAST & AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 135. EUROPE, MIDDLE EAST & AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 136. EUROPE, MIDDLE EAST & AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
• TABLE 137. EUROPE, MIDDLE EAST & AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 138. DENMARK EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 139. DENMARK EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 140. DENMARK EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 141. DENMARK EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 142. DENMARK EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
• TABLE 143. EGYPT EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 144. EGYPT EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 145. EGYPT EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 146. EGYPT EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 147. EGYPT EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
• TABLE 148. FINLAND EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 149. FINLAND EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 150. FINLAND EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 151. FINLAND EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 152. FINLAND EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
• TABLE 153. FRANCE EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 154. FRANCE EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 155. FRANCE EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 156. FRANCE EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 157. FRANCE EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
• TABLE 158. GERMANY EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 159. GERMANY EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 160. GERMANY EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 161. GERMANY EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 162. GERMANY EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
• TABLE 163. ISRAEL EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 164. ISRAEL EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 165. ISRAEL EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 166. ISRAEL EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 167. ISRAEL EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
• TABLE 168. ITALY EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 169. ITALY EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 170. ITALY EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 171. ITALY EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 172. ITALY EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
• TABLE 173. NETHERLANDS EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 174. NETHERLANDS EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 175. NETHERLANDS EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 176. NETHERLANDS EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 177. NETHERLANDS EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
• TABLE 178. NIGERIA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 179. NIGERIA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 180. NIGERIA EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 181. NIGERIA EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 182. NIGERIA EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
• TABLE 183. NORWAY EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 184. NORWAY EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 185. NORWAY EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 186. NORWAY EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 187. NORWAY EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
• TABLE 188. POLAND EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 189. POLAND EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 190. POLAND EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 191. POLAND EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 192. POLAND EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
• TABLE 193. QATAR EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 194. QATAR EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 195. QATAR EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 196. QATAR EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 197. QATAR EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
• TABLE 198. RUSSIA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 199. RUSSIA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 200. RUSSIA EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 201. RUSSIA EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 202. RUSSIA EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
• TABLE 203. SAUDI ARABIA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 204. SAUDI ARABIA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 205. SAUDI ARABIA EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 206. SAUDI ARABIA EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 207. SAUDI ARABIA EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
• TABLE 208. SOUTH AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 209. SOUTH AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 210. SOUTH AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 211. SOUTH AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 212. SOUTH AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
• TABLE 213. SPAIN EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 214. SPAIN EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 215. SPAIN EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 216. SPAIN EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 217. SPAIN EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
• TABLE 218. SWEDEN EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 219. SWEDEN EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 220. SWEDEN EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 221. SWEDEN EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 222. SWEDEN EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
• TABLE 223. SWITZERLAND EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 224. SWITZERLAND EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 225. SWITZERLAND EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 226. SWITZERLAND EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 227. SWITZERLAND EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
• TABLE 228. TURKEY EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 229. TURKEY EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 230. TURKEY EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 231. TURKEY EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 232. TURKEY EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
• TABLE 233. UNITED ARAB EMIRATES EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 234. UNITED ARAB EMIRATES EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 235. UNITED ARAB EMIRATES EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 236. UNITED ARAB EMIRATES EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 237. UNITED ARAB EMIRATES EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
• TABLE 238. UNITED KINGDOM EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 239. UNITED KINGDOM EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 240. UNITED KINGDOM EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 241. UNITED KINGDOM EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 242. UNITED KINGDOM EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
• TABLE 243. EMBOLIZATION PARTICLE MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 244. EMBOLIZATION PARTICLE MARKET, FPNV POSITIONING MATRIX, 2023

The Embolization Particle Market was valued at USD 1.60 billion in 2023, expected to reach USD 1.79 billion in 2024, and is projected to grow at a CAGR of 11.21%, to USD 3.37 billion by 2030.

Embolization particles refer to tiny spheres or other shaped materials used in medical procedures to block blood vessels, thereby controlling or preventing bleeding, cutting off blood supply to tumors, or addressing arteriovenous malformations. Their necessity in the medical field is significant due to their minimally invasive nature and efficacy in treating complex conditions like uterine fibroids, liver cancer, and gastrointestinal bleeding. The end-use scope primarily includes hospitals and specialized clinical settings, which rely on advanced interventional radiology techniques. Market growth for embolization particles is driven by increasing demand for minimally invasive surgery, advances in radiological procedures, and an aging population prone to vascular diseases and cancer. Potential opportunities lie in expanding applications in oncology and personalized medicine as technological advancements make tailored treatment approaches more effective. Emerging markets with improving healthcare infrastructure also offer lucrative opportunities for market expansion. Companies can capture these opportunities by investing in research to develop novel embolic materials with enhanced biocompatibility and targeting capabilities. However, limitations such as high costs, regulatory challenges, and risks associated with procedures present obstacles to market growth. Training and skill requirements for conducting such procedures can also be a restraint in regions where interventional radiology is still developing. Key areas of innovation include developing biodegradable and drug-eluting particles, which can enhance safety and therapeutic outcomes. Leveraging artificial intelligence for improved imaging and targeting precision during procedures represents another avenue for growth. The nature of this market is both technology-driven and highly competitive, demanding continuous innovation and adherence to strict regulatory standards. Businesses should focus on partnerships with healthcare institutions for clinical trials and feedback, as well as engaging with regulatory bodies early in the development cycle to streamline approval processes and reduce time-to-market for new products.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Embolization Particle Market

The Embolization Particle Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Technological integration with imaging modalities improves precision and efficacy of embolization procedures
  • Enhanced training programs for healthcare professionals increase proficiency in using embolization technologies
  • Patient-centric approaches and customized treatment plans gain prominence in embolization practices
• Market Restraints
  • High cost of embolization procedures and particles
• Market Opportunities
  • Increasing demand for minimally invasive procedures to drive growth in embolization particle market
  • Technological advancements and innovation leading to superior performance and new applications of embolization particles
  • Government and private sector investments boosting research and development in embolization particle technologies
• Market Challenges
  • Complications and risks associated with embolization

Porter's Five Forces: A Strategic Tool for Navigating the Embolization Particle Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Embolization Particle Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Embolization Particle Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Embolization Particle Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Embolization Particle Market

A detailed market share analysis in the Embolization Particle Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Embolization Particle Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Embolization Particle Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Embolization Particle Market

A strategic analysis of the Embolization Particle Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Embolization Particle Market, highlighting leading vendors and their innovative profiles. These include ABK Biomedical, Bellostent, Biocompatibles International plc, Boston Scientific Corporation, BTG plc, Cook Medical, EndoShape, Guerbet Group, Hanger Inc., Imbiotechnologies, Johnson & Johnson, Kaneka Corporation, Medtronic plc, Merit Medical Systems, Penumbra Inc., Sequent Medical, Sirtex Medical, Stryker Corporation, and Terumo Corporation.

Market Segmentation & Coverage

This research report categorizes the Embolization Particle Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product Type, market is studied across Drug-Eluting Beads, Microspheres, PVA Particles, Radioembolization Particles, and Tris-Acryl Gelatin Particles.
• Based on Application, market is studied across Neurology, Oncology, Peripheral Vascular Disease, and Urology.
• Based on End-User, market is studied across Ambulatory Surgical Centers, Hospitals, Research and Academic Institutes, and Specialty Clinics.
• Based on Material, market is studied across Acrylic Polymers, Gelatin, and Polyvinyl Alcohol (PVA).
• Based on Size, market is studied across 100-300 Microns, 300-500 Microns, 500-700 Microns, 700-900 Microns, 900 Microns and Above, and Less Than 100 Microns.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Technological integration with imaging modalities improves precision and efficacy of embolization procedures
    • 5.1.1.2. Enhanced training programs for healthcare professionals increase proficiency in using embolization technologies
    • 5.1.1.3. Patient-centric approaches and customized treatment plans gain prominence in embolization practices
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of embolization procedures and particles
  • 5.1.3. Opportunities
    • 5.1.3.1. Increasing demand for minimally invasive procedures to drive growth in embolization particle market
    • 5.1.3.2. Technological advancements and innovation leading to superior performance and new applications of embolization particles
    • 5.1.3.3. Government and private sector investments boosting research and development in embolization particle technologies
  • 5.1.4. Challenges
    • 5.1.4.1. Complications and risks associated with embolization
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Embolization Particle Market, by Product Type

• 6.1. Introduction
• 6.2. Drug-Eluting Beads
• 6.3. Microspheres
• 6.4. PVA Particles
• 6.5. Radioembolization Particles
• 6.6. Tris-Acryl Gelatin Particles

7. Embolization Particle Market, by Application

• 7.1. Introduction
• 7.2. Neurology
• 7.3. Oncology
• 7.4. Peripheral Vascular Disease
• 7.5. Urology

8. Embolization Particle Market, by End-User

• 8.1. Introduction
• 8.2. Ambulatory Surgical Centers
• 8.3. Hospitals
• 8.4. Research and Academic Institutes
• 8.5. Specialty Clinics

9. Embolization Particle Market, by Material

• 9.1. Introduction
• 9.2. Acrylic Polymers
• 9.3. Gelatin
• 9.4. Polyvinyl Alcohol (PVA)

10. Embolization Particle Market, by Size

• 10.1. Introduction
• 10.2. 100-300 Microns
• 10.3. 300-500 Microns
• 10.4. 500-700 Microns
• 10.5. 700-900 Microns
• 10.6. 900 Microns and Above
• 10.7. Less Than 100 Microns

11. Americas Embolization Particle Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Embolization Particle Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Embolization Particle Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2023
• 14.2. FPNV Positioning Matrix, 2023
• 14.3. Competitive Scenario Analysis
• 14.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. ABK Biomedical
• 2. Bellostent
• 3. Biocompatibles International plc
• 4. Boston Scientific Corporation
• 5. BTG plc
• 6. Cook Medical
• 7. EndoShape
• 8. Guerbet Group
• 9. Hanger Inc.
• 10. Imbiotechnologies
• 11. Johnson & Johnson
• 12. Kaneka Corporation
• 13. Medtronic plc
• 14. Merit Medical Systems
• 15. Penumbra Inc.
• 16. Sequent Medical
• 17. Sirtex Medical
• 18. Stryker Corporation
• 19. Terumo Corporation